Informação sobre produto
- (2S)-3-[4-(Acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- (2R)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- (2S)-3-(4-Acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
- GTx 007
- Propanamide, 3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-, (2S)-
- S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide
- S4
- Sarm S-4
Andarine is a selective androgen receptor modulator (SARM) that is currently being studied as a potential treatment for prostate cancer. Andarine binds to the AR with high affinity and specificity, and has been shown to inhibit the growth of prostate cancer cells in vitro. It also inhibits the production of prostate-specific antigen (PSA) in human prostate cancer cells, which may be related to its ability to inhibit the activity of protein kinase C (PKC). In addition, Andarine has been shown to have anti-estrogenic effects in breast cancer cells by inhibiting 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2), a key enzyme in estrogen synthesis. Andarine has not yet been tested on humans, but has been found to cause few side effects in animals.
Propriedades químicas
Consulta técnica sobre: 3D-FA17901 Andarine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.